These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1506358)

  • 1. Circulating neuropeptide Y does not produce pulmonary hypertension during massive sympathetic activation.
    Lang SA; Maron MB; Maender KC; Pilati CF
    J Appl Physiol (1985); 1992 Jul; 73(1):117-22. PubMed ID: 1506358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of neuropeptide Y on hemodynamics of the rabbit lung.
    Lang SA; Maron MB
    J Appl Physiol (1985); 1998 Feb; 84(2):618-23. PubMed ID: 9475874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vasoconstriction in a canine model of neurogenic pulmonary edema.
    Maron MB
    J Appl Physiol (1985); 1990 Mar; 68(3):912-8. PubMed ID: 2341357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen consumption after massive sympathetic nervous system discharge.
    Lang SA; Maron MB; Signs SA
    Am J Physiol; 1989 Mar; 256(3 Pt 1):E345-51. PubMed ID: 2923204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal component to pulmonary hypertension caused by nicotine administration in the dog.
    Maron MB; Rickaby DA; Dawson CA
    J Appl Physiol Respir Environ Exerc Physiol; 1980 Jul; 49(1):66-72. PubMed ID: 7399993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
    Moreau P; de Champlain J; Yamaguchi N
    J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart.
    Warner MR; Senanayake PD; Ferrario CM; Levy MN
    Circ Res; 1991 Aug; 69(2):455-65. PubMed ID: 1776971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors].
    Poncet MF; Tavernier G; Damase-Michel C; Tran MA; Berlan M; Montastruc JL; Montastruc P
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1239-41. PubMed ID: 1659347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects.
    Chalmers J; Morris M; Kapoor V; Cain M; Elliott J; Russell A; Pilowsky P; Minson J; West M; Wing L
    Clin Exp Hypertens A; 1989; 11 Suppl 1():59-66. PubMed ID: 2743605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine liver releases neuropeptide Y during sympathetic nerve stimulation.
    Taborsky GJ; Beltramini LM; Brown M; Veith RC; Kowalyk S
    Am J Physiol; 1994 May; 266(5 Pt 1):E804-12. PubMed ID: 8203518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
    Lundberg JM; Fried G; Pernow J; Theodorsson-Norheim E
    Acta Physiol Scand; 1986 Feb; 126(2):231-8. PubMed ID: 3754683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic vascular control of the laryngeo-tracheal, bronchial and pulmonary circulation in the pig: evidence for non-adrenergic mechanisms involving neuropeptide Y.
    Franco-Cereceda A; Matran R; Alving K; Lundberg JM
    Acta Physiol Scand; 1995 Oct; 155(2):193-204. PubMed ID: 8669292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
    Pernow J; Lundberg JM; Kaijser L
    J Cardiovasc Pharmacol; 1988; 12(5):593-9. PubMed ID: 2468060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation?
    Tavernier G; Damase-Michel C; Portolan G; Tran MA; Montastruc JL
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):431-6. PubMed ID: 1620243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuropeptide-Y on renal function and its interaction with sympathetic stimulation in conscious dogs.
    Persson PB; Ehmke H; Nafz B; Lang R; Hackenthal E; Nobiling R; Dietrich MS; Kirchheim HR
    J Physiol; 1991 Dec; 444():289-302. PubMed ID: 1688030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of EDRF in the cardiopulmonary dysfunction produced by massive sympathetic activation.
    Pilati CF; Maron MB; Bosso FJ
    J Appl Physiol (1985); 1995 May; 78(5):1642-50. PubMed ID: 7649898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential action of hepatic sympathetic neuropeptides: metabolic action of galanin, vascular action of NPY.
    Mundinger TO; Taborsky GJ
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E390-7. PubMed ID: 10710492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and differential sympathetic control of splenic blood flow and capacitance function in the pig and dog.
    Modin A; Pernow J; Lundberg JM
    Acta Physiol Scand; 1993 Jan; 147(1):15-25. PubMed ID: 8095766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.